Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Role of TP53 in repair of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human transitional cell carcinoma of the urinary bladder.

Torino JL, Burger MS, Reznikoff CA, Swaminathan S.

Carcinogenesis. 2001 Jan;22(1):147-54.

PMID:
11159753
2.

Genetic alterations and biological pathways in human bladder cancer pathogenesis.

Reznikoff CA, Sarkar S, Jülicher KP, Burger MS, Puthenveettil JA, Jarrard DF, Newton MA.

Urol Oncol. 2000 Sep 1;5(5):191-203.

PMID:
10973707
3.

Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.

Sarkar S, Jülicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR, Grossman TB, Nickells RW, Protzel C, Jarrard DF, Reznikoff CA.

Cancer Res. 2000 Jul 15;60(14):3862-71.

4.

Replicative senescence in human uroepithelial cells.

Puthenveettil JA, Burger MS, Reznikoff CA.

Adv Exp Med Biol. 1999;462:83-91.

PMID:
10599415
5.

Dominant genetic alterations in immortalization: role for 20q gain.

Cuthill S, Agarwal P, Sarkar S, Savelieva E, Reznikoff CA.

Genes Chromosomes Cancer. 1999 Dec;26(4):304-11.

PMID:
10534765
6.

p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.

Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM, Reznikoff CA.

Cancer Res. 1999 Jun 15;59(12):2957-64.

7.

On the statistical analysis of allelic-loss data.

Newton MA, Gould MN, Reznikoff CA, Haag JD.

Stat Med. 1998 Jul 15;17(13):1425-45.

PMID:
9695190
8.

Methotrexate resistance in human uroepithelial cells with p53 alterations.

Yeager TR, Reznikoff CA.

J Urol. 1998 Feb;159(2):581-5.

PMID:
9649296
9.

Overcoming cellular senescence in human cancer pathogenesis.

Yeager TR, DeVries S, Jarrard DF, Kao C, Nakada SY, Moon TD, Bruskewitz R, Stadler WM, Meisner LF, Gilchrist KW, Newton MA, Waldman FM, Reznikoff CA.

Genes Dev. 1998 Jan 15;12(2):163-74.

10.

Telomerase activity: a biomarker of cell proliferation, not malignant transformation.

Belair CD, Yeager TR, Lopez PM, Reznikoff CA.

Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13677-82.

11.

Minimal deletion of 3p13-->14.2 associated with immortalization of human uroepithelial cells.

Vieten L, Belair CD, Savelieva L, Jülicher K, Bröcker F, Bardenheuer W, Schütte J, Opalka B, Reznikoff CA.

Genes Chromosomes Cancer. 1998 Jan;21(1):39-48.

PMID:
9443040
12.

Quantitative changes in cytoskeletal and nuclear actins during cellular transformation.

Rao JY, Bonner RB, Hurst RE, Liang YY, Reznikoff CA, Hemstreet GP 3rd.

Int J Cancer. 1997 Feb 7;70(4):423-9.

13.
14.

Transformation in vitro of a nontumorigenic rat urothelial cell line by hydrogen peroxide.

Okamoto M, Kawai K, Reznikoff CA, Oyasu R.

Cancer Res. 1996 Oct 15;56(20):4649-53.

15.

A molecular genetic model of human bladder cancer pathogenesis.

Reznikoff CA, Belair CD, Yeager TR, Savelieva E, Blelloch RH, Puthenveettil JA, Cuthill S.

Semin Oncol. 1996 Oct;23(5):571-84. Review.

PMID:
8893868
16.

Apoptosis in human papillomavirus16 E7-, but not E6-immortalized human uroepithelial cells.

Puthenveettil JA, Frederickson SM, Reznikoff CA.

Oncogene. 1996 Sep 19;13(6):1123-31.

PMID:
8808685
17.

Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells.

Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA, Stadler WM.

Cancer Res. 1996 Jul 1;56(13):2886-90.

18.

Neoplastic transformation and DNA-binding of 4,4'-methylenebis(2-chloroaniline) in SV40-immortalized human uroepithelial cell lines.

Swaminathan S, Frederickson SM, Hatcher JF, Reznikoff CA, Butler MA, Cheever KL, Savage RE Jr.

Carcinogenesis. 1996 Apr;17(4):857-64.

PMID:
8625501
19.

Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells.

Reznikoff CA, Belair C, Savelieva E, Zhai Y, Pfeifer K, Yeager T, Thompson KJ, DeVries S, Bindley C, Newton MA, et al.

Genes Dev. 1994 Sep 15;8(18):2227-40.

20.

Assessing the significance of chromosome-loss data: where are suppressor genes for bladder cancer?

Newton MA, Wu SQ, Reznikoff CA.

Stat Med. 1994 Apr 30;13(8):839-58.

PMID:
8047739
21.

In vitro radiation-induced neoplastic progression of low-grade uroepithelial tumors.

Pazzaglia S, Chen XR, Aamodt CB, Wu SQ, Kao C, Gilchrist KW, Oyasu R, Reznikoff CA, Ritter MA.

Radiat Res. 1994 Apr;138(1):86-92.

PMID:
8146304
22.

Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.

Frederickson SM, Messing EM, Reznikoff CA, Swaminathan S.

Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):25-32.

23.

Role of SV40 T antigen binding to pRB and p53 in multistep transformation in vitro of human uroepithelial cells.

Kao C, Huang J, Wu SQ, Hauser P, Reznikoff CA.

Carcinogenesis. 1993 Nov;14(11):2297-302.

PMID:
8242858
24.
25.

A molecular genetic model of human bladder carcinogenesis.

Reznikoff CA, Kao C, Messing EM, Newton M, Swaminathan S.

Semin Cancer Biol. 1993 Jun;4(3):143-52. Review.

PMID:
8318690
26.
27.

Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype.

Pink JC, Messing EM, Reznikoff CA, Bryan GT, Swaminathan S.

Drug Metab Dispos. 1992 Jul-Aug;20(4):559-65.

PMID:
1356735
29.

Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells.

Frederickson SM, Hatcher JF, Reznikoff CA, Swaminathan S.

Carcinogenesis. 1992 Jun;13(6):955-61.

PMID:
1600616
30.

Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids.

Pratt CI, Wu SQ, Bhattacharya M, Kao C, Gilchrist KW, Reznikoff CA.

Cancer Genet Cytogenet. 1992 Apr;59(2):180-90.

PMID:
1316224
31.
32.

Induction of thioguanine-resistant mutations in human uroepithelial cells by 4-aminobiphenyl and its N-hydroxy derivatives.

Bookland EA, Reznikoff CA, Lindstrom M, Swaminathan S.

Cancer Res. 1992 Mar 15;52(6):1615-21.

33.

Tumorigenic transformation and neoplastic progression of human uroepithelial cells after exposure in vitro to 4-aminobiphenyl or its metabolites.

Bookland EA, Swaminathan S, Oyasu R, Gilchrist KW, Lindstrom M, Reznikoff CA.

Cancer Res. 1992 Mar 15;52(6):1606-14.

34.

Losses of 3p, 11p, and 13q in EJ/ras-transformable simian virus 40-immortalized human uroepithelial cells.

Kao C, Wu SQ, Bhatthacharya M, Meisner LF, Reznikoff CA.

Genes Chromosomes Cancer. 1992 Mar;4(2):158-68.

PMID:
1373317
35.

Altered regulation of arachidonic acid metabolism by SV40 immortalized human urothelial cells.

Thomas DJ, Jacob AK, Reznikoff CA, Zenser TV, Davis BB.

Carcinogenesis. 1992 Mar;13(3):447-51.

PMID:
1312397
36.

Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.

Pratt CI, Kao CH, Wu SQ, Gilchrist KW, Oyasu R, Reznikoff CA.

Cancer Res. 1992 Feb 1;52(3):688-95.

37.

Epidermal growth factor and its receptor: markers of--and targets for--chemoprevention of bladder cancer.

Messing EM, Reznikoff CA.

J Cell Biochem Suppl. 1992;16I:56-62. Review.

PMID:
1305689
38.
39.

Allelic 3p deletions in high-grade carcinomas after transformation in vitro of human uroepithelial cells.

Klingelhutz AJ, Wu SQ, Bookland EA, Reznikoff CA.

Genes Chromosomes Cancer. 1991 Sep;3(5):346-57.

PMID:
1686726
40.

Cyclic AMP response in SV40 immortalized human bladder cells.

Jacob AK, Thomas DJ, Reznikoff CA, Zenser TV, Davis BB.

Carcinogenesis. 1991 Aug;12(8):1459-63.

PMID:
1650292
41.

Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells.

Wu SQ, Storer BE, Bookland EA, Klingelhutz AJ, Gilchrist KW, Meisner LF, Oyasu R, Reznikoff CA.

Cancer Res. 1991 Jun 15;51(12):3323-6.

42.

EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.

Christian BJ, Kao CH, Wu SQ, Meisner LF, Reznikoff CA.

Cancer Res. 1990 Aug 1;50(15):4779-86.

43.

Adherence of uropathogenic E. coli to differentiated human uroepithelial cells grown in vitro.

Hopkins WJ, Reznikoff CA, Oberley TD, Uehling DT.

J Urol. 1990 Jan;143(1):146-9.

PMID:
2104636
44.

Basis for the differential modulation of the uptake of 5-iododeoxyuridine by 5'-aminothymidine among various cell types.

Vazquez-Padua MA, Fischer PH, Christian BJ, Reznikoff CA.

Cancer Res. 1989 May 1;49(9):2415-21.

45.

Marker chromosome stability associated with neoplastic transformation of human uroepithelial cells.

Wu SQ, Christian BJ, Reznikoff CA, Meisner LF.

Cancer Genet Cytogenet. 1988 Nov;36(1):77-87.

PMID:
2849503
46.

Neoplastic transformation of SV40-immortalized human urinary tract epithelial cells by in vitro exposure to 3-methylcholanthrene.

Reznikoff CA, Loretz LJ, Christian BJ, Wu SQ, Meisner LF.

Carcinogenesis. 1988 Aug;9(8):1427-36.

PMID:
2841047
47.

Cytogenetic instability with balanced chromosome changes in an SV40 transformed human uroepithelial cell line.

Meisner LF, Wu SQ, Christian BJ, Reznikoff CA.

Cancer Res. 1988 Jun 1;48(11):3215-20.

48.

Clonal growth of normal human uroepithelial cells.

Loretz LJ, Reznikoff CA.

In Vitro Cell Dev Biol. 1988 Apr;24(4):333-42.

PMID:
3366754
49.
50.

Characterization of human uroepithelial cells immortalized in vitro by simian virus 40.

Christian BJ, Loretz LJ, Oberley TD, Reznikoff CA.

Cancer Res. 1987 Nov 15;47(22):6066-73.

Supplemental Content

Loading ...
Support Center